KCM
IMGN

Kennedy Capital Management’s Immunogen Inc IMGN Stock Holding History

Kennedy Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-241,032
Closed -$7.15M – 782
2023
Q4 		$7.15M Buy
+241,032
New +$4.8M 0.16% 236
2023
Q2 		– Sell
-200,032
Closed -$768K – 704
2023
Q1 		$768K Sell
200,032
-277,210
-58% -$1.18M 0.02% 513
2022
Q4 		$2.37M Sell
477,242
-417
-0.1% -$2.26K 0.07% 395
2022
Q3 		$2.28M Buy
477,659
+356,952
+296% +$1.88M 0.07% 396
2022
Q2 		$543K Buy
+120,707
New +$524K 0.02% 537
2021
Q1 		– Sell
-179,242
Closed -$1.16M – 714
2020
Q4 		$1.16M Sell
179,242
-1,072,216
-86% -$6.25M 0.03% 542
2020
Q3 		$4.5M Buy
+1,251,458
New +$5.05M 0.13% 302

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kennedy Capital Management's IMGN Position: Q1 2024 in Review

Kennedy Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 241,032 shares — an estimated $7.15M sold.

Kennedy Capital Management first reported a position in IMGN in Q3 2020 and held it in 7 quarters. The position peaked at $7.15M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Kennedy Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 241,032 Immunogen Inc shares in Q1 2024, an estimated $7.15M.
  • Kennedy Capital Management first reported a position in Immunogen Inc in Q3 2020 and held it in 7 quarters.
  • Kennedy Capital Management's Immunogen Inc position peaked at $7.15M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Kennedy Capital Management's 13F filing for Q1 2024, filed 15 May 2024.